Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
& Rui, H
Neoplastic clones exploit genomic plasticity through KRAS driven metabolic reprogramming, TGF--mediated immune evasion, and Notch pathway driven stemness
Reference Gatti, Raschi and De Ponti8 A retrospective study of 81 patients treated with tedizolid for a median of 28 days reported only 6 (7.4%) developed thrombocytopenia during treatment
doi: 10.1016/j.phymed.2025.156645 206 ZhangGHanXXuTLiuMChenGXieLet al
Usage: This product is intended strictly as a research chemical and is limited to scientific research and education only
US$ 29.24
US$ 20.92
US$ 22.66
